VitaDAO
136 FOLLOWERS
Our core mission is the acceleration of research and development (R&D) in the longevity space and the extension of human life and healthspan. To achieve this, VitaDAO collectively funds and digitizes research in the form of IP-NFTs.
VitaDAO
1y ago
In this podcast, I (@aging_scientist) spoke with Dr. Rich Miller about the ins and outs of mouse aging.
The topics we discussed, roughly in this order, included the Interventions Testing Program, rapamycin, mecilizine, and other lifespan-extending drugs. We talked about the importance of genetically heterogenous mouse stocks and the issues with fast-aging progeroid mouse models. We also covered his more recent work on aging rate indicators and the difference between classic biomarkers and aging rate indicators. Finally, we talked about the importance of lifespan research, misuse of the word he ..read more
VitaDAO
1y ago
Slowing aging by a couple of percents would save more money than curing any single disease, be it cancer, heart disease, or diabetes. Aging is, in fact, the major risk factor that all these diseases have in common. For this reason, slowing aging becomes the most efficient path to a sustainable and healthy future for humanity.
To get this message out we started The Aging Science podcast. We will bring you interviews and frank conversations with leading experts in the field of longevity, as well as evidence-based health advice to support you on this journey.
This podcast is brought to you by Vit ..read more
VitaDAO
1y ago
Insights on Grant-making and Systemic Change: Lessons from Impetus and Beyond with Martin Borch Jensen & Lada Nuzhna.
Outline:
0:00 What is Impetus and how did it get started?
3:12 Takeaways from running and creating Impetus Grants
5:04 Playbook for starting a grant-making program.
12:29 Common misunderstandings between the private sector and academia about funding.
14:12 The role of academia in publishing negative results
23:18 The most impactful levers for systemic change ..read more
VitaDAO
1y ago
Dr Joris Deelen leader at the Max Planck for Biology of AGeing since 2020 and is passionate about research on human aging ..read more
VitaDAO
1y ago
Matt Yousefzadeh, Ph.D., is a postdoctoral fellow in the laboratory of Dr. Laura Niedernhofer, Director of the Institute for the Biology of Aging and Metabolism at the University of Minnesota. He is interested in the mechanisms by which endogenous DNA damage and cellular senescence drive aging ..read more
VitaDAO
1y ago
Dr. Mathieu is a co-founder and the acting Chief Executive Officer of Sentinel Environmental where they are building better microbiomes. Co-founder of Advanced Microbiotics, a startup focused on developing therapeutics to combat antibiotic-resistant bacteria. Did his Ph.D. in environmental engineering at Rice University ..read more
VitaDAO
1y ago
Allison Duettmann is the president of Foresight Institute, a non-profit to advance biotech, nanotech, computing for the long-term benefit of life ..read more
VitaDAO
1y ago
Dr. Shahaf Peleg is an Independent group leader, Metabolism and epigenetics in aging, FBN (Rostock ..read more
VitaDAO
1y ago
Meet Tim Peterson - VitaDAO Longevity Steward, Faculty member at Washington University in St. Louis School of Medicine and co-founder of Healthspan Technologies and BIOIO ..read more
VitaDAO
1y ago
Tyler Golato is a Biogerontologist, and creative thinker building a more collaborative and open future. He co-founded Molecule and serves as Chief Scientist. He also co-initiated VitaDAO and PsyDAO and is focused on trying to develop new and innovative ways to improve funding processes in drug discovery and development ..read more